XML 19 R8.htm IDEA: XBRL DOCUMENT v3.6.0.2
STOCK-BASED COMPENSATION
3 Months Ended
Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK-BASED COMPENSATION
3.
STOCK-BASED COMPENSATION
 
The Company’s 2008 Stock Option Plan (“the Plan”) is used to promote our long-term interests by providing a means of attracting and retaining officers, directors and key employees and aligning their interests with those of our shareholders. The Plan is described more fully in Note 10 in the Notes to the Consolidated Financial Statements in our Form 10-K for the year ended September 30, 2016. All options granted under the Plan had an exercise price equal to the market value of the underlying common shares on the date of grant. We expense the estimated fair value of stock options over the vesting periods of the grants. We recognize expense for awards subject to graded vesting using the straight-line attribution method, reduced for estimated forfeitures. Forfeitures are revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates and an adjustment is recognized at that time. The Compensation Committee may also issue non-qualified stock option grants with vesting periods different from the 2008 Plan. As of December 31, 2016, there are 15 shares underlying options outstanding that were granted outside of the Plan. The assumptions used are detailed in Note 10 to the Consolidated Financial Statements in our Form 10-K for the year ended September 30, 2016. Stock based compensation expense for the three months ended December 31, 2016 and 2015 was $10 and $15, respectively.
 
A summary of our stock option activity for the three months ended December 31, 2016 is as follows (in thousands except for share prices):
 
 
 
 
 
Weighted-
 
Weighted-
 
 
 
 
 
Average
 
Average
 
 
 
Options
 
Exercise
 
Grant Date
 
 
 
(shares)
 
Price
 
Fair Value
 
 
 
 
 
 
 
 
 
Outstanding - October 1, 2016
 
 
262
 
$
1.76
 
$
1.39
 
Exercised
 
 
 
 
 
 
 
 
 
Granted
 
 
 
 
 
 
 
 
 
Terminated
 
 
 
 
 
 
 
 
 
Outstanding - December 31, 2016
 
 
262
 
$
1.76
 
$
1.39